Bessemer Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50
| Closed | -$1K | – | 2622 |
|
|
2024
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 1992 |
|
|
2024
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 2003 |
|
|
2023
Q4 | $1K | Sell |
50
-52
| -51% | -$1.05K | ﹤0.01% | 2083 |
|
|
2023
Q3 | $2K | Hold |
102
| – | – | ﹤0.01% | 1948 |
|
|
2023
Q2 | $2K | Buy |
102
+52
| +104% | +$1.18K | ﹤0.01% | 2010 |
|
|
2023
Q1 | $1K | Sell |
50
-562
| -92% | -$13.2K | ﹤0.01% | 1846 |
|
|
2022
Q4 | $12K | Hold |
612
| – | – | ﹤0.01% | 1397 |
|
|
2022
Q3 | $8K | Hold |
612
| – | – | ﹤0.01% | 1596 |
|
|
2022
Q2 | $12K | Hold |
612
| – | – | ﹤0.01% | 1343 |
|
|
2022
Q1 | $19K | Hold |
612
| – | – | ﹤0.01% | 1246 |
|
|
2021
Q4 | $14K | Hold |
612
| – | – | ﹤0.01% | 1344 |
|
|
2021
Q3 | $17K | Hold |
612
| – | – | ﹤0.01% | 1262 |
|
|
2021
Q2 | $24K | Hold |
612
| – | – | ﹤0.01% | 1199 |
|
|
2021
Q1 | $18K | Buy |
+612
| New | +$20.9K | ﹤0.01% | 1194 |
|
|
2019
Q2 | – | Sell |
-5,655
| Closed | -$389K | – | 1659 |
|
|
2019
Q1 | $389K | Sell |
5,655
-4,240
| -43% | -$284K | ﹤0.01% | 856 |
|
|
2018
Q4 | $590K | Buy |
9,895
+70
| +0.7% | +$6.04K | ﹤0.01% | 709 |
|
|
2018
Q3 | $1.14M | Hold |
9,825
| – | – | ﹤0.01% | 545 |
|
|
2018
Q2 | $1.24M | Buy |
9,825
+6,015
| +158% | +$732K | ﹤0.01% | 522 |
|
|
2018
Q1 | $412K | Sell |
3,810
-17,867
| -82% | -$1.98M | ﹤0.01% | 839 |
|
|
2017
Q4 | $2.37M | Buy |
21,677
+2,313
| +12% | +$231K | 0.01% | 365 |
|
|
2017
Q3 | $1.91M | Buy |
19,364
+6,652
| +52% | +$645K | 0.01% | 451 |
|
|
2017
Q2 | $1.29M | Sell |
12,712
-32
| -0.3% | -$3.45K | 0.01% | 591 |
|
|
2017
Q1 | $1.47M | Sell |
12,744
-139
| -1% | -$16.2K | 0.01% | 591 |
|
|
2016
Q4 | $1.55M | Sell |
12,883
-543,719
| -98% | -$60.2M | 0.01% | 596 |
|
|
2016
Q3 | $62.5M | Sell |
556,602
-549,308
| -50% | -$63.3M | 0.31% | 114 |
|
|
2016
Q2 | $137M | Buy |
1,105,910
+3,784
| +0.3% | +$457K | 0.75% | 35 |
|
|
2016
Q1 | $124M | Buy |
1,102,126
+315,123
| +40% | +$32.7M | 0.7% | 40 |
|
|
2015
Q4 | $85.6M | Buy |
787,003
+387
| +0% | +$44.3K | 0.48% | 77 |
|
|
2015
Q3 | $78.5M | Sell |
786,616
-116
| -0% | -$12.6K | 0.45% | 84 |
|
|
2015
Q2 | $89.7M | Buy |
786,732
+132
| +0% | +$16K | 0.47% | 80 |
|
|
2015
Q1 | $82.2M | Buy |
786,600
+300,000
| +62% | +$32M | 0.42% | 90 |
|
|
2014
Q4 | $58.6M | Buy |
486,600
+485,000
| +30,313% | +$63.7M | 0.32% | 105 |
|
|
2014
Q3 | $234K | Hold |
1,600
| – | – | ﹤0.01% | 670 |
|
|
2014
Q2 | $267K | Sell |
1,600
-96
| -6% | -$17.1K | ﹤0.01% | 651 |
|
|
2014
Q1 | $337K | Sell |
1,696
-107
| -6% | -$20.2K | ﹤0.01% | 595 |
|
|
2013
Q4 | $345K | Buy |
1,803
+1
| +0.1% | +$186 | ﹤0.01% | 595 |
|
|
2013
Q3 | $305K | Buy |
1,802
+120
| +7% | +$18.6K | ﹤0.01% | 613 |
|
|
2013
Q2 | $255K | Buy |
+1,682
| New | +$238K | ﹤0.01% | 548 |
|
Other funds holding CLB
AI
DGI
RA
Bessemer Group's CLB Position: Q3 2024 in Review
Bessemer Group sold out of Core Laboratories (CLB) in Q3 2024, closing a stake of 50 shares — an estimated $1K sold.
Bessemer Group first reported a position in CLB in Q2 2013 and held it in 38 quarters. The position peaked at $137M in Q2 2016. 191 funds tracked by Wall St. Rank hold CLB as of Q3 2024.
- Bessemer Group reported no remaining Core Laboratories position as of Q3 2024 after selling out during the quarter.
- Bessemer Group sold 50 Core Laboratories shares in Q3 2024, an estimated $1K.
- Bessemer Group first reported a position in Core Laboratories in Q2 2013 and held it in 38 quarters.
- Bessemer Group's Core Laboratories position peaked at $137M in Q2 2016.
- 191 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2024.
Based on Bessemer Group's 13F filing for Q3 2024, filed 12 Nov 2024.